Antifungal Drugs Market Top Key Players and Industry Outlook


SUBMITTED BY: nikhilghodse20051994

DATE: July 27, 2022, 6:30 a.m.

FORMAT: Text only

SIZE: 3.2 kB

HITS: 508

  1. The Antifungal Drugs market accounted to US$ 10,182.3 Mn in 2018 and is expected to grow at a CAGR of 3.2% during the forecast period 2019 – 2027, to account to US$ 13,524.2 Mn by 2027.
  2. Global Antifungal Drugs market was segmented by infection type, drug type, therapeutic indication, and dosage form. On the basis of the infection type, the market is segmented as superficial fungal infection and systemic antifungal infection. Based on the drug type, the Antifungal Drugs market is segmented into echinocandins, azoles, polyenes, allylamines, and others. On the basis of the therapeutic indication, the Antifungal Drugs market is segmented into aspergillosis, dermatophytosis, candidiasis, and others. By dosage form, the market is segmented into drugs, ointment, powder, and others.
  3. Get Sample PDF:
  4. https://www.theinsightpartners.com/sample/TIPRE00003745/
  5. The market for Antifungal Drugs is expected to grow significantly due to factors such as rising incidences for the fungal infection of the skin, nails and hair, increasing incidences of cancers, HIV, and hospital-acquired infections and favorable government initiatives to combat the antifungal diseases are likely to drive the growth of the Antifungal Drugs market. However, lack of awareness regarding the fungal infections may restrict the growth of Antifungal Drugs market.
  6. Buy Now: https://www.theinsightpartners.com/buy/TIPRE00003745/
  7. The report segments the global Antifungal Drugs market as follows:
  8. Global Antifungal Drugs Market – By Infection Type
  9. • Superficial Fungal Infection
  10. • Systemic Fungal Infection
  11. Global Antifungal Drugs Market – By Drug Type
  12. • Echinocandins
  13. • Azoles
  14. • Polyenes
  15. • Allylamines
  16. • Others
  17. Global Antifungal Drugs Market – By Therapeutic Indication
  18. • Aspergillosis
  19. • Dermatophytosis
  20. • Candidiasis
  21. • Others
  22. Global Antifungal Drugs Market – By Dosage Form
  23. • Drugs
  24. • Ointment
  25. • Powder
  26. • Others
  27. Global Antifungal Drugs Market – By Geography
  28. • North America
  29. o U.S
  30. o Canada
  31. o Mexico
  32. • Europe
  33. o France
  34. o Germany
  35. o U.K
  36. o Italy
  37. o Spain
  38. • Asia Pacific
  39. o China
  40. o India
  41. o Japan
  42. o Australia
  43. o South Korea
  44. • Middle East & Africa
  45. o Saudi Arabia
  46. o UAE
  47. o South Africa
  48. • South & Central America
  49. o Brazil
  50. o Argentina
  51. Company Profiles
  52. • Pfizer Inc.
  53. • Sanofi S.A.
  54. • Gilead Sciences, Inc.
  55. • Merck And Co., Inc.
  56. • Scynexis Inc.
  57. • Novartis International AG
  58. • Abbott Laboratories
  59. • Bayer AG
  60. • Glenmark Pharmaceutical
  61. • Glaxosmithkline Plc.
  62. About Us:
  63. The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
  64. Contact Us:
  65. If you have any queries about this report or if you would like further information, please contact us:
  66. Contact Person: Sameer Joshi
  67. E-mail: sales@theinsightpartners.com
  68. Phone: +1-646-491-9876

comments powered by Disqus